Related references
Note: Only part of the references are listed.Blockade of αEβ7 integrin suppresses accumulation of CD8+ and Th9 lymphocytes from patients with IBD in the inflamed gut in vivo
Sebastian Zundler et al.
GUT (2017)
T Lymphocytes Expressing AlphaE Beta7 Integrin in Ulcerative Colitis: Associations With Cellular Lineage and Phenotype
Christopher A. Lamb et al.
JOURNAL OF CROHNS & COLITIS (2017)
Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases
Julajak Limsrivilai et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis
Gaik W. Tew et al.
GASTROENTEROLOGY (2016)
Assessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis
Xiaohui Wei et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab
Tim Wyant et al.
JOURNAL OF CROHNS & COLITIS (2016)
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
Giulia Roda et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database
Megan E. McAuliffe et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Essential role for CD103+cells in the pathogenesis of spondyloarthritides
Jean-Marie Berthelot et al.
JOINT BONE SPINE (2015)
Review article: anti-adhesion therapies for inflammatory bowel disease
T. Lobaton et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Distinct Chemokine Signaling Regulates lntegrin Ligand Specificity to Dictate Tissue-Specific Lymphocyte Homing
Hao Sun et al.
DEVELOPMENTAL CELL (2014)
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
Severine Vermeire et al.
LANCET (2014)
TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells
Katharina Gerlach et al.
NATURE IMMUNOLOGY (2014)
Adverse events in IBD: to stop or continue immune suppressant and biologic treatment
Leon P. McLean et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2014)
One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2
W. J. Sandborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
Paul J. Rutgeerts et al.
GUT (2013)
Intraepithelial Type 1 Innate Lymphoid Cells Are a Unique Subset of IL-12-and IL-15-Responsive IFN-γ-Producing Cells
Anja Fuchs et al.
IMMUNITY (2013)
Distribution and Compartmentalization of Human Circulating and Tissue-Resident Memory T Cell Subsets
Taheri Sathaliyawala et al.
IMMUNITY (2013)
Dietary gluten triggers concomitant activation of CD4+ and CD8+ αβ T cells and γδ T cells in celiac disease
Arnold Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Inhibition of Selective Adhesion Molecules in Treatment of Inflammatory Bowel Disease
Nilanjan Ghosh et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2012)
The Yin and Yang of Immunomodulatory Biologics: Assessing the Delicate Balance between Benefit and Risk
Dimitry M. Danilenko et al.
TOXICOLOGIC PATHOLOGY (2012)
A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes
E. G. Stefanich et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
CNS Elevation of Vascular and Not Mucosal Addressin Cell Adhesion Molecules in Patients with Multiple Sclerosis
Rachel Allavena et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Progressive Multifocal Leukoencephalopathy and Newer Biological Agents
Joseph R. Berger
DRUG SAFETY (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
Gert Van Assche et al.
JOURNAL OF CROHNS & COLITIS (2010)
Natalizumab treatment reduces endothelial activity in MS patients
Alban Millonig et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Management of Crohn's Disease in Adults
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Impact of Infectious and Inflammatory Disease on Cytochrome P450-Mediated Drug Metabolism and Pharmacokinetics
E. T. Morgan
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Role of β7 Integrins in Intestinal Lymphocyte Homing and Retention
G. Gorfu et al.
CURRENT MOLECULAR MEDICINE (2009)
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
F. Schnitzler et al.
GUT (2009)
Anti-integrin monoclonal antibodies
Adam Byron et al.
JOURNAL OF CELL SCIENCE (2009)
α4 Integrin/FN-CS1 mediated leukocyte adhesion to brain microvascular endothelial cells under flow conditions
Shumei Man et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
CCL25 and CCL28 promote α4β7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow
Alice Miles et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
Brian G. Feagan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Contribution of TIA-1+ and granzyme B+ cytotoxic T lymphocytes to cryptal apoptosis and ulceration in active inflammatory bowel disease
Hiroyuki Mitomi et al.
PATHOLOGY RESEARCH AND PRACTICE (2007)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Natalizumab induction and maintenance therapy for Crohn's disease
WJ Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Treatment of ulcerative colitis with a humanized antibody to the α4β7 integrin
BG Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Bioassay detects soluble MAdCAM-1 in body fluids
E Leung et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Regional transport and metabolism of roivacaine and its CYP3A4 metabolite PPX in human intestine
S Berggren et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)
Preferential expression of αEβ7 integrin (CD103) on CD8+T cells in the psoriatic epidermis:: regulation by interleukins 4 and 12 and transforming growth factor-β
Y Teraki et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Integrins: Bidirectional, allosteric signaling machines
RO Hynes
CELL (2002)
Role of integrin αE(CD103)β7 for tissue-specific epidermal localization of CD8+ T lymphocytes
K Pauls et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
WA Faubion et al.
GASTROENTEROLOGY (2001)
MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease)
AJ Grant et al.
HEPATOLOGY (2001)
Advances in immunology: T-cell function and migration - Two sides of the same coin
UH von Andrian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
